# US 5,858,774 A · Antisense DNA constructs for expression of hybrid MRNAs driven by inducible, tissue-specific promoters

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,858,774 A
- Document ID: US5858774A
- Status: Granted
- Kind: A
- Application number: 08/543,559
- Filed: 1995-10-16
- Granted: 1999-01-12
- Earliest claimed: 1994-05-12
- Assignees: The Research Foundation of State University of New York
- Inventors: Craig C. Malbon; Christopher M. Moxham
- Web page: https://patentgrep.com/patent/US5858774A

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 9/88: Lyases (4.)
- A01K 2217/075: inducing loss of function, i.e. knock out
- C07K 2319/00: Fusion polypeptide
- C12N 2310/111: spanning the whole gene, or a large part of it
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A gene is regulated by introducing into a cell an inducible, tissue-specific antisense DNA construct. The antisense DNA construct comprises any inducible, tissue-specific gene, into which a DNA sequence antisense to any DNA sequence of the gene targeted for regulation has been inserted. The inducible, tissue-specific antisense DNA construct transcribes a hybrid messenger RNA containing an RNA sequence antisense to a sequence of the messenger RNA of the gene targeted for regulation. The hybrid messenger RNA also contains the RNA sequence of the inducible, tissue-specific gene. Some examples of suitable inducible genes include those selected from the group consisting of mammalian cytosolic phosphoenolpyruvate carboxykinase (PEPCK) (GTP, EC 4.1.1.32), mammalian atrial natriuretic factor (ANF), and mammalian alpha myosin heavy chain (.alpha.-MHC). In a preferred embodiment, the inducible, tissue-specific gene is the rat PEPCK gene.

## Claims

### Claim 1

An inducible, tissue-specific antisense DNA construct comprising an inducible, tissue-specific gene, into which a DNA sequence antisense to a DNA sequence of a gene targeted for regulation has been inserted;
wherein the the antisense DNA construct transcribes a hybrid messenger RNA that comprises:
an RNA sequence antisense to a sequence of the messenger RNA of the gene targeted for regulation; and
the RNA sequence of the inducible, tissue-specific gene.

### Claim 2 (depends on 1)

The inducible, tissue-specific antisense DNA construct of claim 1, wherein said inducible, tissue-specific gene is selected from the group consisting of mammalian cytosolic phosphoenolpyruvate carboxykinase (PEPCK), mammalian atrial natriuretic factor (ANF), and mammalian alpha myosin heavy chain (.alpha.-MHC).

### Claim 3 (depends on 2)

The inducible, tissue-specific antisense DNA construct of claim 2, wherein said inducible, tissue-specific gene is the rat PEPCK gene.

### Claim 4 (depends on 1)

The inducible, tissue-specific antisense DNA construct of claim 1, wherein said gene targeted for regulation is selected from the group consisting of genes encoding guanosine triphosphate-binding regulatory proteins (G proteins), mammalian G-protein linked receptors, mammalian protein serine/threonine kinases, and mammalian phosphatidylinositol bisphosphate-specific phospholipase C enzymes.

### Claim 5 (depends on 4)

The inducible, tissue-specific antisense DNA construct of claim 4, wherein said gene targeted for regulation is the G protein G.alpha..sub.i2 gene.
